| scholarly article | Q13442814 |
| P2093 | author name string | Anna S F Lok | |
| P2860 | cites work | Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature | Q36204603 |
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update | Q37278241 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains | Q39876916 | ||
| Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. | Q43203665 | ||
| Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues | Q43226767 | ||
| Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function | Q43235917 | ||
| Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa | Q43279592 | ||
| Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. | Q44042291 | ||
| Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a | Q46079918 | ||
| Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b | Q46514441 | ||
| Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children | Q80148569 | ||
| Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy | Q33417353 | ||
| Chronic hepatitis B. | Q34002160 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tenofovir | Q155954 |
| P304 | page(s) | 743-747 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Drug therapy: tenofovir | |
| P478 | volume | 52 |
| Q37651892 | Adverse effects of oral antiviral therapy in chronic hepatitis B. |
| Q38188419 | An update on hepatitis B, D, and E viruses. |
| Q47166676 | Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature. |
| Q45356906 | Prevention and management of drug resistant hepatitis B virus infections. |
| Q37722853 | Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA. |
| Q47098116 | Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study. |
| Q38223361 | Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir. |
Search more.